Drugs /

mabel ctls

Back to Drugs List

Overview

Clinical Trials

View Clinical Trials for mabel ctls

Mabel ctls has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating mabel ctls, 1 is phase 1 (1 open).

EBV Positive is the most frequent biomarker inclusion criterion for mabel ctls clinical trials.

Chronic lymphocytic leukemia, hodgkin lymphoma, and mature T-cell and NK-cell lymphoma/leukemia are the most common diseases being investigated in mabel ctls clinical trials [2].

Top Biomarker Inclusion Criteria for Open Clinical Trials Investigating Mabel Ctls
This graph displays the 20 most frequently occurring biomarkers curated on clinical trials investigating mabel ctls and the cancer types associated with these biomarkers. These numbers are derived from a set of 5,956 clinical trials for which biomarker status defines treatment.

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.